n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride has been researched along with ritanserin in 1 studies
Studies (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Trials (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Recent Studies (post-2010) (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Studies (ritanserin) | Trials (ritanserin) | Recent Studies (post-2010) (ritanserin) |
---|---|---|---|---|---|
98 | 0 | 29 | 735 | 75 | 71 |
Protein | Taxonomy | n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride (IC50) | ritanserin (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0012 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.001 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
Diacylglycerol kinase alpha | Homo sapiens (human) | 9 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0025 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0025 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0012 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0025 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araki, H; Ogawa, S; Okuyama, S; Otomo, S | 1 |
1 other study(ies) available for n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and ritanserin
Article | Year |
---|---|
Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced cognitive dysfunction.
Topics: Animals; Anisoles; Anti-Anxiety Agents; Cognition Disorders; Drug Interactions; Ligands; Male; Phencyclidine; Physical Exertion; Piperidines; Propylamines; Pyrimidines; Rats; Rats, Wistar; Receptors, sigma; Ritanserin; Swimming | 1994 |